Skip to content

Zoetis ZTS Non-US — Goodwill

Similar metrics at other companies

First Advantage Corporation logo
FAInternational — Goodwill
$115.16M-0.2%
Radiant Logistics logo
RLGTUS — Goodwill
$101.45M
AMC Entertainment Holdings logo
AMCNon Us — Goodwill
$595.4M+5.3%
AMC Entertainment Holdings logo
AMCNon Us — Goodwill Gross
$1.66B+3.1%
Bausch Health Companies logo
BHCInternational — Goodwill
$880M+6.2%
Xometry, Inc. logo
XMTRNon Us — Goodwill
$5.6M+12.0%

Other financials

Income statement

See full
Revenue$2.3B+2.9%
Gross profit$1.6B+2.6%
Net income$601.0M-0.2%
EPS (diluted)$1.42+6.0%

Balance sheet

See full
Cash & equivalents$1.9B+8.9%
Total debt$10.0B+48.0%
Total equity$3.2B-30.5%
Total assets$15.2B+7.5%

Cash flow

See full
Operating cash flow$401.0M-22.1%
CapEx$110.0M-38.2%
Free cash flow$291.0M-13.6%

Valuation

See full
Market cap$31.9B-54.6%
Enterprise value$39.95B-47.2%
P/E12.1×-15.1×
P/S3.4×-4.1×

Profitability

See full
Gross margin71.8%+0.8pp
Net margin27.8%+0.9pp
FCF margin23.5%0.0pp

Returns & leverage

See full
Return on equity67%+15.8pp
Debt / equity3.1×+1.6×
Current ratio3.2×+1.4×

Where this comes from

Reported directly by Zoetis in its filing.

Tagged under the XBRL concept us-gaap:Goodwill.

The official record: Zoetis’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Zoetis's non-us — goodwill.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Zoetis's non-us — goodwill?
Zoetis (ZTS) reported non-us — goodwill of $1.26B in Q1 2026.
What does non-us — goodwill mean?
This metric represents the portion of goodwill specifically allocated to the company's international or non-domestic operating segments. It reflects the premium paid over the fair value of net identifiable assets for acquisitions that primarily expanded the company's footprint outside of its home country. Monitoring this balance helps investors assess the carrying value of international business units and potential impairment risks related to foreign market performance.